APA
Macrae F. L., Peacock-Young B., Bowman P., Baker S. R., Quested S., Linton E., Hillmen P., Griffin M., Munir T., Payne D., McKinley C., Clarke D., Newton D. J., Hill A. & Ariëns R. A. S. (20200917). Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab. : American journal of hematology.
Chicago
Macrae Fraser L, Peacock-Young Barnaby, Bowman Polly, Baker Stephen R, Quested Sam, Linton Emma, Hillmen Peter, Griffin Morag, Munir Talha, Payne Daniel, McKinley Claire, Clarke Deborah, Newton Darren J, Hill Anita and Ariëns Robert A S. 20200917. Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab. : American journal of hematology.
Harvard
Macrae F. L., Peacock-Young B., Bowman P., Baker S. R., Quested S., Linton E., Hillmen P., Griffin M., Munir T., Payne D., McKinley C., Clarke D., Newton D. J., Hill A. and Ariëns R. A. S. (20200917). Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab. : American journal of hematology.
MLA
Macrae Fraser L, Peacock-Young Barnaby, Bowman Polly, Baker Stephen R, Quested Sam, Linton Emma, Hillmen Peter, Griffin Morag, Munir Talha, Payne Daniel, McKinley Claire, Clarke Deborah, Newton Darren J, Hill Anita and Ariëns Robert A S. Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab. : American journal of hematology. 20200917.